Vitalhub (TSE:VHI) Price Target Raised to C$12.50

Vitalhub (TSE:VHI) had its target price raised by Canaccord Genuity Group from C$12.00 to C$12.50 in a research report released on Thursday,BayStreet.CA reports. They currently have a buy rating on the stock.

Other equities analysts have also issued research reports about the stock. Cormark increased their price target on shares of Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a research report on Wednesday, October 2nd. TD Securities upgraded shares of Vitalhub to a “strong-buy” rating in a research note on Monday, November 25th. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of C$10.05.

Vitalhub Price Performance

Shares of VHI stock opened at C$11.13 on Thursday. The firm has a market capitalization of C$565.96 million, a P/E ratio of 101.18, a P/E/G ratio of 1.18 and a beta of 1.26. The company’s fifty day moving average price is C$11.11 and its two-hundred day moving average price is C$9.42. Vitalhub has a 12 month low of C$4.00 and a 12 month high of C$12.09.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.